News

AXIM Moving Ahead with Testing of Cannabinoid Products, Including Chewing Gum for MS Patients

AXIM Biotechnologies Ā announced it has secured financing from private sources to continue its testing of medicalĀ cannabinoid products as potential treatments forĀ multiple indications, includingĀ pain and spasticity in people with multiple sclerosis (MS). Specifically, AXIM Ā is testing pharmaceutical delivery systems andĀ active ingredients for itsĀ medical marijuana line. ā€œThis financing provides us with…

Getting More Blacks and Other Minority MS Patients into Clinical Studies Is Goal of ACP Project

Getting more African-Americans and other minority groups to take part in clinical research into treatments for multiple sclerosis (MS), andĀ identifying and tackling continuing disparities in efforts that affect patient care, will be the focus of a project led by the nonprofit groupĀ Accelerated Cure Project for Multiple Sclerosis (ACP)Ā and supported…

Selexis to Provide ImmuNext with Cell Lines for Research into Treatment for MS, Autoimmune Diseases

SelexisĀ has entered into a commercial arrangementĀ with ImmuNext,Ā providing that company with access to research cell banks from itsĀ SURE technologyĀ Platform (a best-in-class cell line development technology). ImmuNext will use the cell banks in further developing its anti-CD40 ligand antibody, a potential therapeutic agentĀ for chronic autoimmune disorders such as multiple sclerosis…

Shake, Rattle, and Spill? Tremors in MS

I live in a part of the country with beautiful green forests, mountains, abundant freshwater, and saltwater.Ā  If you have seven hours to spare, you can drive across the state and experience desert, orchard, mountain, alpine meadow, rainforest, and the Pacific Ocean. This beautiful land also comes with some…

Genome-wide Analysis Pinpoints 200 Gene Variants Common to MS

A genome-wide analysis of over 110,000 peopleĀ allowed researchersĀ withĀ theĀ International Multiple Sclerosis Genetics Consortium (IMSGC)Ā to discoverĀ 200 genetic loci (the position of genes on a chromosome) that areĀ common to peopleĀ withĀ multiple sclerosis (MS). The findings were given in theĀ presentation, ā€œ200 loci complete the genetic puzzle of multiple sclerosis,ā€ by Dr. Nikolaos…

RedHill Awaits Patent for RHB-104, Potential MS Treatment, from Japan

RedHill BiopharmaĀ recentlyĀ announcedĀ that it hasĀ received a Notice of Allowance from theĀ Japan Patent Office for a new patent coveringĀ RHB-104 as a potentialĀ treatment of multiple sclerosis (MS).Ā Once granted, the patent will be valid until 2032. The European Patent Office also recently approvedĀ a patent application for the drug with this…

Apitope Regains Full Rights to Potential MS Therapy, ATX-MS-1467

ApitopeĀ andĀ Merck KGaAĀ announced that they have entered into an exclusive agreement regardingĀ ATX-MS-1467, a potential disease-modifying therapy for Ā multiple sclerosis (MS). Under itsĀ terms, Apitope will regain full global rights over ATX-MS-1467, as well as allĀ clinical data related to the compound. In 2009, the companyĀ grantedĀ exclusive global rights toĀ Merck KGaA to develop…

Wheat Proteins Known as ATIs May Worsen Inflammation in People with MS

A group of proteins found in wheat can cause symptoms ofĀ suchĀ inflammatory health conditions as multiple sclerosis (MS), asthma and rheumatoid arthritis to worsen, and may alsoĀ promote gluten sensitivity, according to researchers atĀ Johannes Gutenberg UniversityĀ inĀ Germany. These findings, recently presented atĀ United European Gastroenterology (UEG) Week 2016, turn attention away from one…

National Multiple Sclerosis Society Commits $10.5M to Fund 42 Research Efforts

The National Multiple Sclerosis SocietyĀ announced thatĀ is investing more than $10.5 million to support an anticipatedĀ 42 new research projects intoĀ multiple sclerosis (MS), part of its commitmentĀ to scientificĀ efforts aimed atĀ stopping MS, restoring lost function to patients, and, ultimately, ending the disease forever. The dedicated fundingĀ is part of aĀ projected society investment of…

Heparin for MD Myelin Repair to Be Studied in United Kingdom

The MS SocietyĀ in the United Kingdom is funding a new project at the University of Glasgow, in Scotland,Ā to examine if Ā heparin, a drug widely used for stroke patients, can repair neurological damage in people with multiple sclerosis (MS). MS is a progressive, debilitating, immune-mediated, neurodegenerative disorder in which…

Stress Urinary Incontinence Can Often Affect Mothers with Relapsing MS

Stress urinary incontinence affects predominantly young adult mothers with relapsing-remitting multiple sclerosis (RRMS), particularly those with pelvic organ prolapse, according to a recent study. Exercises that strengthen theĀ pelvic floor muscles are suggested to reduce the risk ofĀ incontinence. The study, ā€œStress Urinary Incontinence in Women With Multiple Sclerosis,ā€…

Vocalist Lori Jenaire Supports #25for25 Campaign for Autoimmune Diseases with ‘As You Are’ Classic Cover

Singer-songwriterĀ Lori Jenaire is supporting the American Autoimmune Related Diseases Association (AARDA) #25for25 fundraising campaign with the release of her Top Five Billboard Hot Singles Sales debut “As You Are,” featuringĀ Patrice Rushen. The song is a remake of the 1978 Pharoah Sanders’ R&B soulĀ classic, which in its original version featuredĀ Phyllis…

New Urinary Catheter, Designed by Quadriplegic, Approved by FDA

The U.S. Food and Drug Administration (FDA) approved for marketingĀ Adapta Medicalā€™s PerfIC Cath, an intermittent and easy-to-useĀ urinary catheter that wasĀ designed for patients with limited dexterity by a doctor who isĀ alsoĀ a quadriplegic. Urinary tract symptoms can troubleĀ peopleĀ with multiple sclerosis (MS). In fact, according to the National MS Society,…